|
1
|
Kleiner DE, Brunt EM, Wilson LA, Behling
C, Guy C, Contos M, Cummings O, Yeh M, Gill R, Chalasani N, et al:
Association of histologic disease activity with progression of
nonalcoholic fatty liver disease. JAMA Netw Open. 2:e19125652019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rhee EJ: Nonalcoholic fatty liver disease
and diabetes: An epidemiological perspective. Endocrinol Metab
(Seoul). 34:226–233. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gomaraschi M, Fracanzani AL, Dongiovanni
P, Pavanello C, Giorgio E, Da Dalt L, Norata GD, Calabresi L,
Consonni D, Lombardi R, et al: Lipid accumulation impairs lysosomal
acid lipase activity in hepatocytes: Evidence in NAFLD patients and
cell cultures. Biochim Biophys Acta Mol Cell Biol Lipids.
1864:1585232019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Y, Wong GL, He FP, Sun J, Chan AW,
Yang J, Shu SS, Liang X, Tse YK, Fan XT, et al: Quantifying and
monitoring fibrosis in non-alcoholic fatty liver disease using
dual-photon microscopy. Gut. 69:1116–1126. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang MH, Chang KJ, Li B and Chen WS:
Arsenic trioxide suppresses tumor growth through antiangiogenesis
via notch signaling blockade in small-cell lung cancer. Biomed Res
Int. 2019:46472522019.PubMed/NCBI
|
|
6
|
Yamamoto S, Schulze KL and Bellen HJ:
Introduction to Notch signaling. Methods Mol Biol. 1187:1–14. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xiao W, Chen X and He M: Inhibition of the
Jagged/Notch pathway inhibits retinoblastoma cell proliferation via
suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β-catenin signaling
pathways. Mol Med Rep. 10:453–458. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aithal MGS and Rajeswari N: Bacoside a
induced Sub-G0 arrest and early apoptosis in human glioblastoma
cell line U-87 MG through Notch signaling pathway. Brain Tumor Res
Treat. 7:25–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jensen CH, Kosmina R, Rydén M, Baun C,
Hvidsten S, Andersen MS, Christensen LL, Gastaldelli A, Marraccini
P, Arner P, et al: The imprinted gene Delta like non-canonical
notch ligand 1 (Dlk1) associates with obesity and triggers insulin
resistance through inhibition of skeletal muscle glucose uptake.
EBioMedicine. 46:368–380. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang KC, Chuang PY, Yang TY, Huang TW and
Chang SF: Hyperglycemia inhibits osteoblastogenesis of rat bone
marrow stromal cells via activation of the Notch2 signaling
pathway. Int J Med Sci. 16:696–703. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Trovato FM, Martines GF, Brischetto D,
Catalano D, Musumeci G and Trovato GM: Fatty liver disease and
lifestyle in youngsters: Diet, food intake frequency, exercise,
sleep shortage and fashion. Liver Int. 36:427–433. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen C, Zhu Z, Mao Y, Xu Y, Du J, Tang X
and Cao H: HbA1c may contribute to the development of non-alcoholic
fatty liver disease even at normal-range levels. Biosci Rep.
40:BSR201939962020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Romeo S: Notch and Nonalcoholic fatty
liver and fibrosis. N Engl J Med. 380:681–683. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niture S, Gyamfi MA, Kedir H, Arthur E,
Ressom H, Deep G and Kumar D: Serotonin induced hepatic steatosis
is associated with modulation of autophagy and notch signaling
pathway. Cell Commun Signal. 16:782018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamada T, Obata A, Kashiwagi Y, Rokugawa
T, Matsushima S, Hamada T, Watabe H and Abe K:
Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of
nonalcoholic steatohepatitis (NASH) in mice. Magn Reson Imaging.
34:724–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Larter CZ, Yeh MM, Williams J,
Bell-Anderson KS and Farrell GC: MCD-induced steatohepatitis is
associated with hepatic adiponectin resistance and adipogenic
transformation of hepatocytes. J Hepatol. 49:407–416. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu LY, Qiu LW, Chen XF, Lü L and Mei ZC:
Oleic acid induced hepatic steatosis is coupled with downregulation
of aquaporin 3 and upregulation of aquaporin 9 via activation of
p38 signaling. Horm Metab Res. 13:125–129. 2014.
|
|
19
|
Shakir AK, Suneja U, Short KR and Palle S:
Overview of pediatric nonalcoholic fatty liver disease: A guide for
general practitioners. J Okla State Med Assoc. 111:806–811.
2018.PubMed/NCBI
|
|
20
|
Lee J, Park JS and Roh YS: Molecular
insights into the role of mitochondria in non-alcoholic fatty liver
disease. Arch Pharm Res. 42:935–946. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sutti S and Albano E: Adaptive immunity:
An emerging player in the progression of NAFLD. Nat Rev
Gastroenterol Hepatol. 17:81–92. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Thorne JL and Moore JB: Vitamin D
and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab
Care. 22:449–458. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Trovato FM, Castrogiovanni P, Szychlinska
MA, Purrello F and Musumeci G: Early effects of high-fat diet,
extra-virgin olive oil and vitamin D in a sedentary rat model of
non-alcoholic fatty liver disease. Histol Histopathol.
33:1201–1213. 2018.PubMed/NCBI
|
|
24
|
Aleĭnik AN and Kondakova IV: The Notch
signaling systemand oncogenesis. Vopr Onkol. 58:593–597. 2012.(In
Russian). PubMed/NCBI
|
|
25
|
Dang TP: Notch, apoptosis and cancer. Adv
Exp Med Biol. 727:199–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Geisler F and Strazzabosco M: Emerging
roles of Notch signaling in liver disease. Hepatology. 61:382–392.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun L, Sun G, Yu Y and Coy DH: Is Notch
signaling a specific target in hepatocellular carcinoma? Anticancer
Agents Med Chem. 15:809–815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aimaiti Y, Yusufukadier M, Li W,
Tuerhongjiang T, Shadike A, Meiheriayi A, Gulisitan, Abudusalamu A,
Wang H, Tuerganaili A, et al: TGF-β1 signaling activates hepatic
stellate cells through Notch pathway. Cytotechnology. 71:881–891.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang L, Chen J, Yong J, Qiao L, Xu L and
Liu C: An essential role of RNF187 in Notch1 mediated metastasis of
hepatocellular carcinoma. J Exp Clin Cancer Res. 38:3842019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu C, Kim K, Wang X, Bartolome A, Salomao
M, Dongiovanni P, Meroni M, Graham MJ, Yates KP, Diehl AM, et al:
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic
steatohepatitis. Sci Transl Med. 10:eaat03442018. View Article : Google Scholar : PubMed/NCBI
|
